Regeneron Pharmaceuticals sees strength in Dupixent, oncology gains, and major buybacks despite setbacks. Find out why REGN ...

MP Materials announces a public-private partnership with the US Department of Defense to accelerate the build-out of an ...

A version of this article appears in print on Sept. 27, 2023, Section D, Page 6 of the New York edition with the headline: What’s Fresh and Exciting in Los Angeles.